Frazier Life Sciences IX, L.P. 13D and 13G filings for Phathom Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-09-26 4:00 pm Purchase | 2022-09-22 | 13D | PHATHOM PHARMACEUTICALS INC CO PHAT | Frazier Life Sciences IX, L.P. | 8,424,772 21.500% | 203,448 (+2.47%) | Filing |
| 2022-08-11 3:55 pm Purchase | 2022-08-09 | 13D | PHATHOM PHARMACEUTICALS INC CO PHAT | Frazier Life Sciences IX, L.P. | 8,221,324 21.000% | 2,377,400 (+40.68%) | Filing |